HONG KONG – A series of enquiries in Australia into tax payments by multinational pharmaceutical companies is likely to have little impact on their operations, particularly outside the country, despite the concern of authorities there. Read More

HONG KONG – The mechanism by which the thalidomide derivative lenalidomide treats a type of myelodysplastic syndrome (MDS) has been elucidated, reported in the July 1, 2015, edition of Nature, could aid the development of new therapies for leukemias and other malignancies. Read More

Jun Bao, senior vice president and chief business officer of Shenogen Pharma Group, begins nearly every presentation about the company with a slide that features strikingly different images. At the top is a simple photo of the ubiquitous Epimedium wushanense, commonly known as horny goat weed, a hardy perennial that grows mainly in China and has been widely used in traditional Chinese medicine (TCM) as an aphrodisiac and a treatment for erectile dysfunction. Shenogen's lead molecule, icaritin, is derived from the plant. Read More

The latest Scientific American Worldview Scorecard, released at the recent BIO 2015 International Convention, which ranks the biotechnology innovation potential of 54 countries, finds that the U.S. is the leading country once again based on its performance in seven categories used in the study, with Denmark and three Asia-Pacific countries – New Zealand, Australia and Singapore – rounding out the top five. Read More

Lupin Ltd., of Mumbai, India, said it acquired a 100 percent equity stake in Zao Biocom in Russia, marking its first foray into the Russian pharmaceutical market. Specific terms were not disclosed. Read More